Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer.
Quick Facts
What This Study Found
Multi-peptide vaccines combining CD8+ killer T cell and CD4+ helper T cell epitopes with adjuvants represent the most promising approach for cancer peptide vaccines. Overcoming MHC restriction and the immunosuppressive tumor microenvironment remain key challenges.
Key Numbers
Not specified (review covering vaccine design principles, MHC restriction, and tumor microenvironment strategies)
How They Did This
Comprehensive review integrating vaccine chemistry, cancer immunology (CTL/CD4+ responses, MHC restriction, tumor microenvironment), and clinical trial outcomes for peptide-based cancer vaccines.
Why This Research Matters
Peptide cancer vaccines have historically underperformed. This review identifies the specific advances in immunology, vaccine chemistry, and tumor biology that may finally make them clinically effective.
What This Study Doesn't Tell Us
Review of a field with a history of clinical failures. Many proposed strategies are still preclinical. Translating immunological insights to clinical success remains unproven.
Trust & Context
- Original Title:
- Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer.
- Published In:
- NPJ vaccines, 10(1), 68 (2025)
- Database ID:
- RPEP-13523
Evidence Hierarchy
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-13523APA
Shah, Bansari A; Holden, James A; Lenzo, Jason C; Hadjigol, Sara; O'Brien-Simpson, Neil M. (2025). Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer.. NPJ vaccines, 10(1), 68. https://doi.org/10.1038/s41541-025-01118-9
MLA
Shah, Bansari A, et al. "Multi-disciplinary approaches paving the way for clinically effective peptide vaccines for cancer.." NPJ vaccines, 2025. https://doi.org/10.1038/s41541-025-01118-9
RethinkPeptides
RethinkPeptides Research Database. "Multi-disciplinary approaches paving the way for clinically ..." RPEP-13523. Retrieved from https://rethinkpeptides.com/research/shah-2025-multidisciplinary-approaches-paving-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.